What is the dosage of Zejula?

Zejula is available in 1 dosages, including 100 mg Cap

What is Zejula mechanism of action?

Zejula mechanism of action is Poly(ADP-Ribose) Polymerase Inhibitors

Zejula Prescribing & Dosing Schedule

Q: What does Zejula treat?

Zejula treats Fallopian Tube Neoplasms, Ovarian Neoplasms and Peritoneal Neoplasms

Q: What is Zejula made of?

Zejula contains niraparib which is a Poly(ADP-Ribose) Polymerase Inhibitor

Q: How is Zejula administered?

Zejula is administered as a Oral Pill

Last Update: Oct, 06 2024

Zejula(niraparib)

Zejula 100 MG Oral Capsule

NO BOXED WARNING

Dosage & Administration

* First-line maintenance treatment of advanced ovarian cancer:
* For patients weighing <77 kg (<170 lbs) OR with a platelet count <150,000/mcL, the recommended dosage is 200 mg taken orally once daily.
* For patients weighing ≥77 kg (≥170 lbs) AND a platelet count ≥150,000/ mcL, the recommended dosage is 300 mg taken orally once daily.

* Maintenance treatment of recurrent germline BRCA-mutated ovarian cancer: The recommended dosage is 300 mg taken orally once daily.
* Continue treatment until disease progression or unacceptable toxicity.
* ZEJULA may be taken with or without food.
* For adverse reactions, consider interruption of treatment, dose reduction, or dose discontinuation.
* For patients with moderate hepatic impairment, reduce the starting dosage of niraparib to 200 mg once daily.

Most viewed Zejula resources

Enroll in Patient Savings Program

Get Your Patient on Zejula

Find restrictionsSee step therapiesCompare coverage options

Zejula Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Zejula Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Appeals

Complete Letter of Medical Necessity

Benefits investigation

Zejula Service Request Form

Zejula Financial Assistance Options

Copay savings program

Zejula Service Request Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

Zejula Service Request Form

Quick Start & Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

Zejula Service Request Form

GSK Patient Assistance Program Eligibiligy & Enrollment

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

Zejula PubMed™ News

Zejula Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Zejula FAQs

How is the dosage of Zejula?

What does Zejula treat?

What is Zejula made of?

How Is Zejula Administered?

What Are The Zejula Mechanism Of Action?

FAQ Data Source